Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Weichselbaum

Showing results (31-40 of 364) with videos related to

Pageof 37
Sort By:
Current Opinion in Pharmacology|October 16, 2012
Cholesterol metabolism and resistance to tamoxifenMarc Poirot, Sandrine Silvente-Poirot, Ralph R Weichselbaum
Frontiers in Oncology|October 23, 2012
The confluence of radiotherapy and immunotherapyByron Burnette, Yang-Xin Fu, Ralph R Weichselbaum
Cancer Cell|July 4, 2025
The dark side of radiotherapyAndrás Piffkó, Sean P Pitroda, Ralph R Weichselbaum
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genesSunil J Advani, Ralph R Weichselbaum, Bernard Roizman
European Journal of Cancer (Oxford, England : 1990)|March 2, 2024
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equalJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Staging the Metastatic Spectrum Through Integration of Clinical and Molecular FeaturesCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2019
Integration of radiotherapy and immunotherapy for treatment of oligometastasesSean P Pitroda, Steven J Chmura, Ralph R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Cancer|December 7, 2018
Oligometastatic prostate cancer: Reality or figment of imagination?Corey C Foster, Ralph R Weichselbaum, Sean P Pitroda
Pageof 37

Showing results (31-40 of 364) with videos related to

Sort By:
Pageof 37
Current Opinion in Pharmacology|October 16, 2012
Cholesterol metabolism and resistance to tamoxifenMarc Poirot, Sandrine Silvente-Poirot, Ralph R Weichselbaum
Frontiers in Oncology|October 23, 2012
The confluence of radiotherapy and immunotherapyByron Burnette, Yang-Xin Fu, Ralph R Weichselbaum
Cancer Cell|July 4, 2025
The dark side of radiotherapyAndrás Piffkó, Sean P Pitroda, Ralph R Weichselbaum
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genesSunil J Advani, Ralph R Weichselbaum, Bernard Roizman
European Journal of Cancer (Oxford, England : 1990)|March 2, 2024
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equalJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2019
Staging the Metastatic Spectrum Through Integration of Clinical and Molecular FeaturesCorey C Foster, Sean P Pitroda, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2019
Integration of radiotherapy and immunotherapy for treatment of oligometastasesSean P Pitroda, Steven J Chmura, Ralph R Weichselbaum
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Cancer|December 7, 2018
Oligometastatic prostate cancer: Reality or figment of imagination?Corey C Foster, Ralph R Weichselbaum, Sean P Pitroda
Pageof 37